Abstract
Parkinson's disease is a common and often debilitating disorder, with a growing prevalence accompanying global population aging. Current drug therapy is not satisfactory enough for many patients, especially after a few years of symptom progression. This is mainly due to the motor complications that frequently emerge as disease progresses. Deep brain stimulation (DBS) is a useful therapeutic option in carefully selected patients that significantly improves motor symptoms, functional status, and quality of life. However, cognitive impairment may limit patient selection for DBS, as patients need to have sufficient mental capabilities in order to understand the procedure, as well as its benefits and limitations, and cooperate with the medical team throughout the process of selection, surgery, and postsurgical follow-up. On the other hand it has been observed that certain aspects of cognitive performance may decline after DBS, namely when the therapeutic target is the widely used subthalamic nucleus. These are important pieces of information for patients, their families, and health care professionals. This manuscript reviews these aspects and their clinical implications.
Citations
Jul 21, 2012·Der Nervenarzt·F Steigerwald, J Volkmann
May 18, 2013·Journal of Neurology·Han-Joon KimSun Ha Paek
Oct 11, 2012·Neurology Research International·Edward A Shipton
Jun 22, 2014·IEEE Transactions on Neural Systems and Rehabilitation Engineering : a Publication of the IEEE Engineering in Medicine and Biology Society·Samantha R SummersonCaleb T Kemere
Apr 2, 2014·Journal of Neurology·Han-Joon KimGwanhee Ehm
Aug 26, 2015·Parkinsonism & Related Disorders·Mallory L HackerDavid Charles
Jun 16, 2015·Parkinsonism & Related Disorders·Lars DinkelbachMartin Südmeyer
Oct 9, 2015·PloS One·Jean-François HouvenaghelPaul Sauleau
Aug 16, 2014·Journal of the Neurological Sciences·Alaina BordenDavid Maltête
Oct 28, 2017·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Alexander I Tröster
Jul 14, 2018·PloS One·Claire HaegelenXavier Morandi
Jun 9, 2018·The International Journal of Neuroscience·Asmat Ullah KhanRida Zainab
Dec 17, 2018·Journal of Neurosurgery·Jennifer MullerChengyuan Wu
Oct 11, 2017·International Psychogeriatrics·Hamilton MorrinAnto P Rajkumar
Sep 28, 2016·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Alfonso FasanoRenato Puppi Munhoz
Dec 14, 2017·Applied Neuropsychology. Adult·Joseph A Mole, Simon J Prangnell
Jul 7, 2019·Acta neurochirurgica·Maidinamu YakufujiangYasuo Iwadate
Oct 1, 2012·Dementia & Neuropsychologia·Alessandra Shenandoa HeluaniJosé Oswaldo de Oliveira
Oct 27, 2018·Movement Disorders Clinical Practice·Laura J WeinkleOlga Klepitskaya
May 30, 2014·Neurologia Medico-chirurgica·Takashi AsahiSatoshi Kuroda
Sep 26, 2019·Frontiers in Neuroscience·Fei SuWarren M Grill
Apr 12, 2016·Journal of Parkinson's Disease·Jean-Paul BouwynDavid Maltête
Jul 5, 2018·Parkinson's Disease·Jennifer A FoleyLisa Cipolotti
Dec 18, 2019·Dementia & Neuropsychologia·Eduarda Naidel Barboza E Barbosa, Helenice Charchat Fichman
Dec 29, 2020·World Neurosurgery·Maidinamu YakufujiangYasuo Iwadate
Jan 3, 2021·Journal of Parkinson's Disease·Katarzyna SmilowskaK Ray Chaudhuri
May 22, 2021·Frontiers in Neurology·Weibing LiuSatoshi Kuwabara
Jun 23, 2021·Journal of Speech, Language, and Hearing Research : JSLHR·Sandra H VosVitória Piai